BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20873444)

  • 1. Epidemiology of major depression in Belgian parkinsonian patients.
    Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V;
    Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees.
    Sławek J; Derejko M; Lass P
    Parkinsonism Relat Disord; 2005 Nov; 11(7):465-8. PubMed ID: 16154794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
    Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
    Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depression and health-related quality of life in Parkinson's disease.
    Jones CA; Pohar SL; Patten SB
    Gen Hosp Psychiatry; 2009; 31(4):334-40. PubMed ID: 19555793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
    Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
    Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode.
    Pintor L; Baillès E; Valldeoriola F; Tolosa E; Martí MJ; de Pablo J
    Gen Hosp Psychiatry; 2006; 28(1):59-64. PubMed ID: 16377367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and major depressive disorder in patients with Parkinson's disease.
    Inoue T; Kitagawa M; Tanaka T; Nakagawa S; Koyama T
    Mov Disord; 2010 Jan; 25(1):44-9. PubMed ID: 20014057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Mov Disord; 2008 Sep; 23(12):1739-43. PubMed ID: 18661550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for anxiety symptoms in Parkinson disease: a cross-sectional study.
    Stefanova E; Ziropadja L; Petrović M; Stojković T; Kostić V
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):34-40. PubMed ID: 23407399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
    Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
    Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease.
    Roh JH; Kim BJ; Jang JH; Seo WK; Lee SH; Kim JH; Oh K; Park KW; Lee DH; Koh SB
    Acta Neurol Scand; 2009 Jun; 119(6):397-403. PubMed ID: 18976321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.